{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:40:51Z","timestamp":1789663251001,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.prp.2024.155327","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T16:28:53Z","timestamp":1714408133000},"page":"155327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV"],"prefix":"10.1016","volume":"258","author":[{"given":"Mostafa A.","family":"Sharafeldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda A.","family":"Suef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel A.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina H.","family":"Ziadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.S.","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prp.2024.155327_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228857","article-title":"The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.prp.2024.155327_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/ejim.ejim_29_18","article-title":"Characterization of patients with hepatocellular carcinoma on the way to early detection: one center experience","volume":"30","author":"Elgamal","year":"2018","journal-title":"Egypt. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155327_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66507-7","article-title":"Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma","volume":"10","author":"Benhammou","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155327_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.950374","article-title":"The Key Role of microRNAs in initiation and progression of hepatocellular carcinoma","volume":"12","author":"Khan","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155327_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"Clinical practice guidelines, management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2024.155327_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","article-title":"Management of Hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the japan society of hepatology (JSH) 2010 updated version","volume":"29","author":"Kudo","year":"2011","journal-title":"Dig. Dis."},{"issue":"43","key":"10.1016\/j.prp.2024.155327_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027673","article-title":"AFP-L3 for the diagnosis of early hepatocellular carcinoma","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2024.155327_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.25122\/jml-2019-0076","article-title":"Signification of serum alpha-fetoprotein levels in cases of compensated cirrhosis and hepatitis C virus without hepatocellular carcinoma","volume":"13","author":"Manuc","year":"2020","journal-title":"J. Med. Life"},{"issue":"1\u20132","key":"10.1016\/j.prp.2024.155327_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2008.05.010","article-title":"Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications","volume":"395","author":"Debruyne","year":"2008","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.prp.2024.155327_bib10","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.2007.262","article-title":"New perspectives and strategy research biomarkers for hepatocellular carcinoma","volume":"45","author":"Saffroy","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.prp.2024.155327_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","article-title":"Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma","volume":"28","author":"Hanif","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.prp.2024.155327_bib12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1572-0241.2000.02091.x","article-title":"Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation","volume":"95","author":"Gambarin-Gelwan","year":"2000","journal-title":"Am. J. Gastroenterol."},{"issue":"1-2","key":"10.1016\/j.prp.2024.155327_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mrrev.2008.01.005","article-title":"Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention","volume":"659","author":"Anwar","year":"2008","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.prp.2024.155327_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000333261","article-title":"Controversies in surveillance and early diagnosis of hepatocellular carcinoma","volume":"81","author":"Kim","year":"2011","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.prp.2024.155327_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting cancer-promoting inflammation \u2014 have anti-inflammatory therapies come of age?","volume":"18","author":"Hou","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2024.155327_bib16","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.7314\/APJCP.2015.16.9.3595","article-title":"Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma","volume":"16","author":"Wang","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.prp.2024.155327_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-\u03b2: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.prp.2024.155327_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1874357901812010026","article-title":"Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma","volume":"12","author":"Petruzziello","year":"2018","journal-title":"Open Virol. J."},{"key":"10.1016\/j.prp.2024.155327_bib19","series-title":"in: Hepatocellular Carcinoma - Basic Research","article-title":"New Molecular Biomarkers Candidates for the Development of Multiparametric Platforms for Hepatocellular Carcinoma Diagnosis, Prognosis and Personalised Therapy","author":"Serafino","year":"2012"},{"issue":"0","key":"10.1016\/j.prp.2024.155327_bib20","doi-asserted-by":"crossref","DOI":"10.21608\/bmfj.2022.175414.1712","article-title":"Hepatocellular carcinoma detection in hepatitis C virus-related cirrhosis by glypican-3","volume":"0","author":"Kandil","year":"2022","journal-title":"Benha Med. J."},{"issue":"1","key":"10.1016\/j.prp.2024.155327_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-05444-z","article-title":"Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019","volume":"12","author":"Nakano","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2024.155327_bib22","article-title":"Liver cirrhosis with its complications: Case report in a young female patient, Asian Australas","volume":"4","author":"Mahyuddin","year":"2022","journal-title":"Neuro Health Sci. J. (AANHS-J. )"},{"key":"10.1016\/j.prp.2024.155327_bib23","series-title":"in: Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma","first-page":"275","article-title":"Theranostic and precision medicine for the diagnosis of hepatocellular carcinoma","author":"Miret","year":"2022"},{"issue":"11","key":"10.1016\/j.prp.2024.155327_bib24","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3748\/wjg.v12.i11.1681","article-title":"Interleukin-10 and chronic liver disease","volume":"12","author":"Zhang","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.prp.2024.155327_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5114\/ceh.2018.73484","article-title":"Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis","volume":"4","author":"Shakiba","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2024.155327_bib26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.1997.4861382.x","article-title":"Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-\u03b1) receptors in type C chronic liver disease","volume":"109","author":"Kakumu","year":"1997","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2024.155327_bib27","doi-asserted-by":"crossref","DOI":"10.4066\/biomedicalresearch.29-17-1550","article-title":"Alpha-fetoprotein: a fabulous biomarker in hepatocellular, gastric and rectal cancer diagnosis","volume":"29","author":"Naz","year":"2018","journal-title":"Biomed. Res."},{"key":"10.1016\/j.prp.2024.155327_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004836-200103000-00014","article-title":"Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C","volume":"32","author":"Chu","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"issue":"17","key":"10.1016\/j.prp.2024.155327_bib29","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.3390\/jcm11175075","article-title":"Diagnostic performance of AFP, AFP-L3, or PIVKA-II for hepatitis C virus-associated hepatocellular carcinoma: a multicenter analysis","volume":"11","author":"Liu","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155327_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"\u03b1-fetoprotein, Des-\u03b3 carboxyprothrombin, and lectin-bound \u03b1-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.prp.2024.155327_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2009.10.031","article-title":"Des-\u03b3-carboxy prothrombin and \u03b1-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma","volume":"138","author":"Lok","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.prp.2024.155327_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1155\/2012\/962320","article-title":"Serological biomarkers of hepatocellular carcinoma in Egyptian patients","volume":"32","author":"El-Tayeh","year":"2012","journal-title":"Dis. Markers"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824002383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824002383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T17:38:26Z","timestamp":1716658706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824002383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S0344033824002383"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155327","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155327"}}